Search Orphan Drug Designations and Approvals
-
Generic Name: | Cytarabine liposomal | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | DepoCyt | ||||||||||||||||
Date Designated: | 06/02/1993 | ||||||||||||||||
Orphan Designation: | Treatment of neoplastic meningitis. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Pacira Pharmaceuticals, Inc. 10450 Science Center Drive San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Cytarabine liposomal |
---|---|---|
Trade Name: | DepoCyt | |
Marketing Approval Date: | 04/01/1999 | |
Approved Labeled Indication: | Intrathecal treatment of lymphomatous meningitis. | |
Exclusivity End Date: | 04/01/2006 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-